Twist Bioscience Corporation TWST Cash Flow Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$81.28M+57.5% | -$76.58M+61.2% | -$77.67M+62.8% | -$85.19M+61.3% | -$191.15M+0.5% | ||
| $24.68M-11.0% | $24.67M-16.8% | $24.85M-20.9% | $25.51M-23.4% | $27.74M-17.1% | ||
| $64.35M+10.2% | $65.74M+26.7% | $64.46M+26.6% | $60.72M+20.7% | $58.4M+23.8% | ||
| $14.62M— | $11.11M— | $22.47M— | —— | —— | ||
| $12.65M+233% | $9.4M+228% | $4.23M+153% | -$2.55M+67.6% | -$9.52M+0.2% | ||
| $4.74M+1,285% | $5.38M+385% | $9.62M+181% | $4.74M— | $342K— | ||
| -$1.79M-147% | $4.12M-11.4% | $5.75M+30.3% | $3.72M-31.6% | $3.83M— | ||
| $1.38M+201% | $1.01M+447% | $1.59M+436% | $622K+178% | $459K— | ||
| -$558K— | -$1.89M— | -$2.2M— | -$2.5M— | —— | ||
| —— | —— | $0— | $0+100% | $0+100% | ||
| -$55.59M+0.9% | -$51.01M+18.4% | -$47.63M+25.7% | -$51.13M+26.4% | -$56.11M+35.1% | ||
| $39.45M+321% | $35.71M+512% | $28M+452% | $17.58M+222% | $9.38M+4.1% | ||
| $49.1M+1.3% | $49.31M-9.0% | $49.39M-4.8% | $49.45M+1.3% | $48.46M-11.7% | ||
| $46.71M-11.7% | $49.36M-3.7% | $50.14M-7.0% | $50.89M+1.3% | $52.89M-33.3% | ||
| -$44.44M-796% | -$33.16M-278% | -$24.76M-706% | -$13.64M-664% | -$4.96M-128% | ||
| —— | —— | —— | —— | —— | ||
| $7.71M-9.9% | $6.69M-26.4% | $9.34M+31.6% | $7.47M+39.5% | $8.55M+206% | ||
| $11.84M-57.2% | $10.89M-58.6% | $28.54M+314% | $26.59M+618% | $27.68M— | ||
| —— | $205K— | $143K— | $53K— | $126K— | ||
| -$88.1M-165% | -$73.07M-62.2% | -$43.71M+27.3% | -$38.13M+45.4% | -$33.27M+53.4% | ||
| $1.33M+3,213% | $864K+165% | $683K+88.2% | $23K-95.8% | $40K-93.6% | ||
| —— | —— | $0— | $0+100% | $0+100% | ||
| —— | —— | —— | —— | —— | ||
| $23.46M— | $11.2M— | $3.72M— | $1.26M— | —— | ||
| -$558K— | -$1.89M— | -$2.2M— | -$2.5M— | —— | ||
| $46.71M-11.7% | $49.36M-3.7% | $50.14M-7.0% | $50.89M+1.3% | $52.89M-33.3% | ||
| $15K-42.3% | $12K-99.2% | $16K-99.6% | $22K-99.6% | $26K-99.6% | ||
| —— | —— | —— | —— | —— | ||
| $7.71M-9.9% | $6.69M-26.4% | $9.34M+31.6% | $7.47M+39.5% | $8.55M+206% | ||
| $6.62M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $0— | $0— | $0— | ||
| $1.33M+3,213% | $864K+165% | $683K+88.2% | $23K-95.8% | $40K-93.6% | ||
| -$95.04M-45.1% | -$86.72M-26.8% | -$75.63M-9.3% | -$68.71M+8.3% | -$65.49M+31.4% | ||
| -$95.04M-45.1% | -$86.72M-26.8% | -$75.63M-9.3% | -$68.71M+8.3% | -$65.49M+31.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Twist Bioscience Corporation generate?
- Twist Bioscience Corporation (TWST) generated -$55.6M in operating cash flow over the trailing twelve months.
- What is Twist Bioscience Corporation's free cash flow?
- After $39.5M of capital expenditures, Twist Bioscience Corporation's free cash flow was -$95.0M over the trailing twelve months, down 45.1% year over year.
- Where does Twist Bioscience Corporation's cash flow data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
